Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFB pathways

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Yang, Yao Jong ^a   Chuang, Ching Chun ^a   Yang, Hsiao Bai ^a,b   Lu, Cheng Chan ^a   Sheu, Bor Shyang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; JANUS KINASE 1; LA5; PROBIOTIC AGENT; SMAD7 PROTEIN; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; SMAD7 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; CYTOTOXICITY; ENZYME INACTIVATION; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION TERMINATION; WESTERN BLOTTING; CELL SURVIVAL; CYTOLOGY; HUMAN; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SIGNAL TRANSDUCTION; STOMACH MUCOSA; TUMOR CELL LINE;

HELICOBACTER PYLORI; LACTOBACILLUS ACIDOPHILUS;

CELL LINE, TUMOR; CELL SURVIVAL; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-8; LACTOBACILLUS ACIDOPHILUS; NF-KAPPA B; PROBIOTICS; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862808083     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-38     Document Type: Article

References (38)

1. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Marshall BJ, Warren JR, Lancet 1984 1 1311 1315 6145023
2. Helicobacter pylori, gastro duodenal disease, and recurrent abdominal pain in children. Macarthur C, Saunders N, Feldman W, J Am Med Assoc 1995 273 729 734 10.1001/jama.1995.03520330059038
3. Helicobacter pylori infection and the development of gastric cancer. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ, N Engl J Med 2001 345 784 789 10.1056/NEJMoa001999 11556297
4. Epithelial NF-B maintains host gut microflora homeostasis. Ben-Neriah Y, Schmidt-Supprian M, Nat Immunol 2007 8 479 781 17440457
5. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Keates S, Hitti YS, Upton M, Kelly CP, Gastroenterology 1997 113 1099 1109 10.1053/gast.1997.v113.pm9322504 9322504 (Pubitemid 27418963)
6. Expression of NFkappaB in Helicobacter pylori infection. Doger FK, Meteoglu I, Ozkara E, Erkul ZK, Okyay P, Yukselen V, Dig Dis Sci 2006 51 2306 2309 10.1007/s10620-006-9352-5 17103034
7. Local cytokine response in Helicobacter pylori-infected subjects. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM, Infect Immun 1998 66 5964 5971 9826379 (Pubitemid 28531859)
8. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, Baldari CT, Romagnani S, Telford JL, Del Prete G, Eur J Immunol 1997 27 1751 1755 10.1002/eji.1830270723 9247587 (Pubitemid 27302859)
9. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G, J Immunol 1997 158 962 967 8993017 (Pubitemid 127492677)
10. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB, Gastroenterology 1998 114 482 492 10.1016/S0016-5085(98)70531-1 9496938 (Pubitemid 28141193)
11. Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. Tsai CC, Hsih HY, Chiu HH, Lai YY, Liu JH, Yu B, Tsen HY, Int J Food Microbiol 2005 102 185 194 10.1016/j.ijfoodmicro.2004.12.014 15992617 (Pubitemid 40898123)
12. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppée JY, Bourdet-Sicard R, Sansonetti PJ, Pédron T, J Immunol 2006 176 1228 1237 16394013 (Pubitemid 43099727)
13. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. Johnson-Henry KC, Nadjafi M, Avitzur Y, Mitchell DJ, Ngan BY, Galindo-Mata E, Jones NL, Sherman PM, J Infect Dis 2005 191 2106 2117 10.1086/430318 15897997 (Pubitemid 40800582)
14. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Francavilla R, Helicobacter 2010 15 79 87 10.1111/j.1523-5378.2009.00743.x 20402810
15. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. Fernandez MF, Boris S, Barbes C, J Appl Microbiol 2003 94 449 455 10.1046/j.1365-2672.2003.01850.x 12588553 (Pubitemid 36315035)
16. Probiotic therapy of intestinal inflammation and infections. Sartor RB, Curr Opin Gastroenterol 2005 21 44 50 15687884 (Pubitemid 40189223)
17. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. De Keersmaecker SC, Verhoeven TL, Desair J, Marchal K, Vanderleyden J, Nagy I, FEMS Microbiol Lett 2006 259 89 96 10.1111/j.1574-6968.2006.00250.x 16684107
18. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA, Am J Physiol 1999 276 941 950 10198338
19. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus Strain LB. Coconnier MH, Lievin V, Hemery E, Servin AL, Appl Env Microbiol 1998 64 4573 4580 (Pubitemid 28538035)
20. The influence of the immunostimulation by bacterial cell components derived from altered large intestinal microbiota on probiotic anti-inflammatory benefits. Matsumoto M, Hara K, Benno Y, FEMS Immunol Med Microbiol 2007 49 387 390 10.1111/j.1574-695X.2007.00215.x 17378901 (Pubitemid 46435015)
21. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. Corr SC, Gahan CG, Hill C, FEMS Immunol Med Microbiol 2007 50 380 388 10.1111/j.1574-695X.2007.00264.x 17537177 (Pubitemid 47041463)
22. Regulation of immune responses by TGF- Letterio JJ, Roberts AB, Annu Rev Immunol 1998 16 137 161 10.1146/annurev.immunol.16.1.137 9597127 (Pubitemid 28183362)
23. Conditional loss of TGF- signaling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Hahm KB, Lee KM, Kim YB, Hong WS, Lee WH, Han SU, Kim MW, Ahn BO, Oh TY, Lee MH, Green J, Kim SJ, Aliment Pharmacol Ther 2002 16 suppl 2 115 127 12047270 (Pubitemid 41771470)
24. Intracellular BMP signaling regulation in vertebrates: pathway or network? von Bubnoff A, Cho KW, Dev Biol 2001 239 1 14 10.1006/dbio.2001.0388 11784015 (Pubitemid 33052049)
25. Smad7 as a therapeutic agent for chronic kidney diseases. Lan HY, Front Biosci 2008 13 4984 4992 18508563
26. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Monteleone G, Del Vecchio Blanco G, Palmieri G, Vavassori P, Monteleone I, Colantoni A, Battista S, Spagnoli LG, Romano M, Borrelli M, MacDonald TT, Pallone F, Gastroenterology 2004 126 674 682 10.1053/j.gastro.2003.11.048 14988821 (Pubitemid 38298315)
27. Local expressions of TGF-beta1, TGF-beta1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis. Li Z, Li J, Scand J Gastroenterol 2006 41 1007 1012 10.1080/00365520600554477 16938712
28. Presence of iceA1 but not cagA, cagC, cagE, cagF, cagN, cagT, or orf13 genes of Helicobacter pylori is associated with more severe gastric inflammation in Taiwanese. Sheu SM, Sheu BS, Yang HB, Li C, Chu TC, Wu JJ, J Formos Med Assoc 2002 101 18 23 11911033 (Pubitemid 34232760)
29. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ, Gut 2003 52 927 932 10.1136/gut.52.7.927 12801945 (Pubitemid 36765280)
30. Bifidobacterium breve enhances transforming growth factor 1 signaling by regulating smad7 expression in preterm infants. Fujii T, Ohtsuka Y, Lee T, Kudo T, Shoji H, Sato H, Nagata S, Shimizu T, Yamashiro Y, J Pediatr Gastroenterol Nutr 2006 43 83 88 10.1097/01.mpg.0000228100.04702.f8 16819382 (Pubitemid 44022391)
31. Differential expression of interleukin-15, a pro-inflammatory cytokine and t-cell growth factor, and its receptor in human prostate. Handisurya A, Steiner GE, Stix U, Ecker RC, Pfaffeneder-Mantai S, Langer D, Kramer G, Memaran-Dadgar N, Marberger M, Prostate 2001 49 251 262 10.1002/pros.10020 11746271 (Pubitemid 33117000)
32. Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Dimberg A, Nilsson K, berg F, Blood 2000 96 2870 2878 11023524
33. Nuclear factor-kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Kim JM, Cho SJ, Oh YK, Jung HY, Kim YJ, Kim N, Clin Exp Immunol 2002 130 59 66 10.1046/j.1365-2249.2002.01921.x 12296854
34. LPS-induced inflammatory cytokine production was inhibited by Hyungbangjihwangtang through blockade of NFkappaB in peripheral blood mononuclear cells. Moon PD, Jeong HJ, Um JY, Kim HM, Hong SH, Int J Neurosci 2007 117 1315 1329 10.1080/00207450600936692 17654094 (Pubitemid 47123627)
35. Double-blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokines. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Gut 2003 52 975 980 10.1136/gut.52.7.975 12801954 (Pubitemid 36765289)
36. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Monteleone G, Pallone F, MacDonald TT, Trends Immunol 2004 25 513 517 10.1016/j.it.2004.07.008 15364052 (Pubitemid 39208348)
37. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT, J Clin Invest 2001 108 601 609 11518734 (Pubitemid 32777740)
38. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. Fiocchi C, J Clin Invest 2001 108 523 526 11518725 (Pubitemid 32777731)